The Brighterside of News on MSN
GLP-1 drugs like Ozempic and Wegovy are changing the foods Americans buy
The impact of popular U.S. weight-loss drugs like Ozempic and Wegovy (GLP-1 receptor agonists), upon their initial ...
Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing ...
MedPage Today on MSN
GLP-1 Agents Showed Broader Risks, Rewards in 2025
Meanwhile, in attempts to address long-standing thyroid cancer concerns, a research team conducted a 350,000-person analysis ...
No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following oral administration. MIAMI, FL / ACCESS Newswire / December 18, 2025 / ...
Morning Overview on MSN
Ozempic might change how alcohol hits you, scientists say
Powerful weight loss drugs are colliding with America’s drinking culture, and scientists say the mix is not as simple as ...
n = number of patients included in each study group for HbA1c and body weight efficacy assessments Abbreviations: EOS: End of Study (week 16); Wk: week; BID: twice daily; CBD: cannabidiol; QD: once ...
LifeVantage announces improved results from its MindBody GLP-1 System clinical trials, showing over 200% average increase in GLP-1. LifeVantage Corporation has revealed promising new results from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results